Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Sympathetic Ablation for Ventricular Arrhythmias

NCT: NCT07501819 · NOT_YET_RECRUITING

NCT IDNCT07501819
StatusNOT_YET_RECRUITING
Start Date2026-04
Completion2027-09

Brief Summary

Enrolled patients will undergo an acute procedure in which a catheter is inserted near the heart to ablate a sympathetic nerve, reducing signals that trigger ventricular arrhythmias.

Frequently Asked Questions

What is Sympathetic Ablation for Ventricular Arrhythmias?

Sympathetic Ablation for Ventricular Arrhythmias is a clinical trial registered under NCT07501819. Current status: NOT_YET_RECRUITING.

What is the status of NCT07501819?

The current status of NCT07501819 (Sympathetic Ablation for Ventricular Arrhythmias) is: NOT_YET_RECRUITING.

When did Sympathetic Ablation for Ventricular Arrhythmias start?

Sympathetic Ablation for Ventricular Arrhythmias started on 2026-04.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑